MBDA

MBDA profile

Q: Where can I research MBDA directly?

Go to the primary sources: MBDA (official site) , MBDA plans $5.8B investment in missile production as demand soars (Breaking Defense, 2026) , With UK military secrets, Ukraine could now build SCALP missiles at home (Defense News, 2026) . Avoid aggregator summaries when the filing itself is available.

By Jonathan Teplitsky · reviewed against primary sources · updated August 26, 2026.

MBDA is the European missile house jointly owned by Airbus, BAE Systems, and Leonardo. It builds the long-range strike weapons Ukraine uses and the air-defence interceptors Europe is buying to stop drones.

What MBDA does

MBDA designs and manufactures missiles for European governments through a joint venture that no single country controls. Airbus and BAE Systems each hold 37.5 percent and Leonardo holds 25 percent. That arrangement is what makes MBDA work and what slows it down. MBDA was formed in December 2001 from Aérospatiale Matra Missiles, Matra BAe Dynamics, and the missile division of Alenia Marconi Systems. It now runs national companies in France, the United Kingdom, Italy, Germany, and Spain, with about 20,000 staff and headquarters at Le Plessis-Robinson near Paris. Revenue reached 5.8 billion euros in 2025 against order intake of 13.2 billion euros and a backlog of 44.4 billion euros. At its current output rate MBDA has booked roughly seven and a half years of work. Closing that gap is what the spending plan is for. MBDA said it would invest 5 billion euros from 2026 through 2030 and hire around 2,800 people in 2026, targeting 40 percent output growth after already doubling production since 2023. The multinational structure is also why a single missile can need several governments to agree before its technology moves, which is the mechanism behind the August 2026 SCALP decision.

The product lines that define the company for research purposes:

Storm Shadow and SCALP-EG air-launched cruise missile
Aster 15 and Aster 30 surface-to-air missiles
CAMM and Sea Ceptor air-defence family
Meteor beyond-visual-range air-to-air missile
Brimstone air-to-surface missile
Exocet, Marte, and Teseo anti-ship missiles
Akeron MP and Akeron RCX 50 and RCH 170 loitering munitions
One-Way Effector long-range attack drones
Mistral and MICA VL short-range air defence

This profile is qualitative by design. It carries no share price, no price target, no valuation multiple, and no rating — those change faster than any page can honestly track, and the filings linked below are the authoritative source for them.

MBDA drone lineup

The current public product record does not identify a complete aircraft lineup.

No complete-aircraft offering is catalogued for this company; it is tracked here as an unmanned-systems enabler.

Statuses are editorial classifications from the company’s current public catalog: active means currently presented for sale, delivery, or program work; development means publicly disclosed but not a mature production offering; legacy means retained for historical or installed-fleet coverage.

Recent contracts & awards

A dated log of the specific contracts, orders, funding, and deployments reported for MBDA, each tied to its primary source. This is a record of what was announced — a "selection", "award", or "partnership" is not the same as obligated money, so read each source before treating a figure as revenue. No figure appears here unless a source reported it.

CertificationAug 24, 2026
UK authorises MBDA to release classified SCALP component data to Ukraine
The United Kingdom authorised MBDA to share classified technical data on British-made SCALP cruise missile components with Ukraine, removing a legal obstacle to Ukrainian domestic production. France had granted a production licence earlier in 2026. The authorisation covers technical data only. It establishes no production contract, no funding, no factory location, and no delivery schedule.
With UK military secrets, Ukraine could now build SCALP missiles at home (Defense News, 2026)
EarningsMar 27, 2026
MBDA plans 5 billion euro investment and about 2,800 hires to raise missile output
MBDA reported 2025 revenue of 5.8 billion euros, order intake of 13.2 billion euros, and a backlog of 44.4 billion euros. Alongside those results it said it would invest 5 billion euros from 2026 through 2030 and hire roughly 2,800 people in 2026. The target is 40 percent output growth, after doubling production since 2023.
MBDA plans $5.8B investment in missile production as demand soars (Breaking Defense, 2026)

Is MBDA going public?

MBDA will not list. It is a joint venture held by Airbus at 37.5 percent, BAE Systems at 37.5 percent, and Leonardo at 25 percent. Its results reach public markets through those three shareholders rather than through a security of its own. That matters to an investor in one specific way. MBDA revenue growth reaches the market as equity income and segment commentary inside Airbus, BAE Systems, and Leonardo reporting, diluted by everything else those companies do.

Where MBDA sits in the value chain

MBDA is a defense contractor whose unmanned work sits inside a wider defense portfolio, so drone headlines are only one input into results and can be offset — in both directions — by unrelated segments.

Its disclosed activity spans aerial drones, counter-UAS, maritime autonomy. That placement is the single most useful thing to fix in your head before reading any coverage, because the same headline means different things at different layers: a large platform award is transformative for a pure-play, material but diluted for a diversified contractor, and only indirectly relevant to a component supplier whose exposure arrives later as build-rate demand. Retail coverage routinely applies one story to all three layers at once. For the layer-by-layer comparison across the sector, see the drone stocks research shortlist and the list of publicly traded drone companies.

Why the Ownership Structure Decides What MBDA Can Sell

MBDA is the only European missile maker whose export decisions can be vetoed by three governments at once. A weapon such as Storm Shadow, sold as SCALP in France, contains components built in more than one member country. Each national government controls the release of its own technology. That is why a French production licence granted earlier in 2026 did not by itself allow Ukrainian manufacturing. British-made components inside the missile still needed separate United Kingdom authorisation, which arrived in August 2026. The same structure that lets MBDA pool European demand into production runs no single national champion could justify is the structure that adds approval steps to every transfer. Companies reading MBDA as a straightforward prime contractor miss this. Its throughput is limited by industrial capacity, and its addressable market is limited by whichever shareholder government is most cautious about a given customer.

Where MBDA Sits in the Counter-Drone Cost Argument

MBDA enters the counter-drone market from the expensive end and has to come down. European air defence against one-way attack drones currently runs on interceptors priced for aircraft and cruise missiles. That wins engagements at a loss. A CAMM or an Aster costs many multiples of the drone it destroys, and a defender who runs out of money before the attacker runs out of airframes has lost. Purpose-built interceptors from Destinus and small-effector programmes elsewhere attack that arithmetic directly. MBDA has two advantages the newcomers do not, in an existing qualified production base and in a customer set that already integrates its missiles into ship and battery fire-control systems. Its disadvantage is margin structure. A company earning 5.8 billion euros a year from exquisite missiles has more to lose by pricing an interceptor near cost than a startup with no legacy line does. Watch how the Akeron RCX and One-Way Effector lines get priced.

What Would Change the Read on the Backlog

A 44.4 billion euro backlog is the strongest fact on this profile and the one most likely to be misread. It represents order intake, and order intake becomes revenue only at the rate the factories deliver. The investment and hiring plan therefore matters more than the backlog figure itself. Three conditions would change the read. A durable ceasefire in Ukraine would slow new intake while leaving years of booked work in place, so the revenue line would keep climbing after the order line stopped. A supply-chain failure in energetics, seekers, or rocket motors would push deliveries right regardless of demand. Those inputs are the documented bottleneck across the European missile industry, ahead of final assembly. And a shift in European air-defence doctrine toward cheap interceptors and directed energy would leave the backlog intact but change what the next cycle of orders contains.

What MBDA Gets Confused With

MBDA is frequently described as French, British, or Italian depending on which national company issued a statement. All three descriptions are partial. MBDA France, MBDA UK, MBDA Italia, MBDA Deutschland, and a small Spanish operation are national entities inside one group headquartered near Paris. Coverage of a Storm Shadow decision in London and a SCALP decision in Paris is often coverage of the same missile. A second confusion is Storm Shadow and SCALP themselves. They are the same air-launched cruise missile under two national names, with a range reported at more than 250 kilometres against fixed, pre-planned targets. A third is scope. MBDA is not a drone maker in the sense the rest of this site uses the word. It appears here because its interceptors are what European navies and armies currently fire at drones, and because the Akeron and One-Way Effector lines have moved it into loitering munitions.

What to watch

The signals worth tracking are structural, not price-based — they tell you whether the business is changing shape, which is what eventually shows up in the numbers.

Whether output growth lands. MBDA targets 40 percent higher missile production in 2026, after doubling since 2023. A backlog of 44.4 billion euros against 5.8 billion euros of revenue puts the constraint in factory throughput and supply chain rather than demand.
Whether the loitering-munition and one-way-effector lines take budget from the missile lines or add to them. Akeron RCX 50, RCH 170, and the One-Way Effector put MBDA into the cheap-attritable category that companies such as Helsing and Destinus were built for. Those unit economics look nothing like the ones an Aster carries.
How the joint-venture structure handles technology transfer. The August 2026 UK authorisation to release classified SCALP component data to Ukraine came after France had already granted a production licence. One weapon needed two national decisions, which is what a three-shareholder, five-country structure costs in approvals.
Whether counter-drone demand pulls CAMM and Mistral downward in cost. European ministries buying interceptors against one thousand euro drones are pushing every missile maker toward a cheaper effector, and MBDA has more production base to defend than the startups do.
Segment disclosure at the three shareholders. Airbus, BAE Systems, and Leonardo each report MBDA differently, and none of them breaks out missile-line profitability, so no shareholder filing gives a clean view of the business.

How to research MBDA

Every question below has one authoritative source, and using the wrong source is how most retail research goes wrong.

Research question	Where the answer lives	What to look for
Is there anything to buy?	SEC EDGAR full-text search	Whether any registration statement exists at all — absent one, there is no public security.
Is the government work real?	Official DoD contract announcements	Awarding service and scope of work, rather than a company-issued announcement.
What is the acquisition pathway?	DIU and DARPA program pages	Whether the work runs through non-traditional agreements or a conventional program of record.
How would exposure even work?	Fund holdings disclosures	Whether any listed vehicle discloses a stake — indirect exposure is usually thin and unstated.

MBDA publishes annual results and a company profile on its own corporate site, and that is the primary source for revenue, order intake, backlog, and headcount. Those figures are company-reported for a private joint venture, and no exchange regulator reviews them.
The three shareholders are the second source. Airbus, BAE Systems, and Leonardo each discuss MBDA in their own reporting. Where their descriptions of the same year differ, the cause is usually accounting treatment of the stake rather than a disagreement about the business.
For anything involving a technology transfer or an export decision, the deciding government publishes before MBDA does. A SCALP or Storm Shadow authorisation appears in United Kingdom or French government announcements first, and MBDA typically does not comment on national release decisions at all.
Product specifications on the MBDA site are the manufacturer's own. Range figures for weapons such as Storm Shadow are reported as "more than" a threshold because the exact number is classified.

One failure mode is worth naming explicitly: a company announcement describing a "selection", "award", or "partnership" is not the same as obligated money, and the two are easy to conflate because they use the same vocabulary. Check the official record before treating either as revenue. Our full approach is documented on the methodology page.

MBDA FAQ

What does MBDA do?

MBDA designs and manufactures missiles for European governments through a joint venture that no single country controls.

Is MBDA publicly traded?

MBDA is not publicly traded, so there is no ticker to buy. Any claim otherwise should be verified against SEC EDGAR before it is believed.

What should investors watch with MBDA?

Whether output growth lands. MBDA targets 40 percent higher missile production in 2026, after doubling since 2023. A backlog of 44.4 billion euros against 5.8 billion euros of revenue puts the constraint in factory throughput and supply chain rather than demand.

Where can I research MBDA directly?

Go to the primary sources: MBDA (official site), MBDA plans $5.8B investment in missile production as demand soars (Breaking Defense, 2026), With UK military secrets, Ukraine could now build SCALP missiles at home (Defense News, 2026). Avoid aggregator summaries when the filing itself is available.

Can you invest in MBDA directly?

No. MBDA is a private joint venture with no listed security. Airbus and BAE Systems each hold 37.5 percent and Leonardo holds 25 percent. Buying any of those three shares gives partial exposure to MBDA results, alongside each company's much larger other businesses.

Are Storm Shadow and SCALP the same missile?

Yes. Storm Shadow is the United Kingdom name and SCALP-EG is the French name for the same MBDA air-launched cruise missile. It is built for precision strikes on fixed, pre-planned targets at a range reported as more than 250 kilometres. News coverage using the two names often describes one weapon and one decision.

Does MBDA make drones?

MBDA builds loitering munitions and one-way attack drones alongside its missile lines, including the Akeron RCX 50, the Akeron RCH 170, and the One-Way Effector family. Those are expendable strike systems rather than reusable aircraft, and they put MBDA in competition with defence-tech startups at unit costs far below an Aster or a Storm Shadow.